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Abstract
Chenodeoxycholate (CDCA) is a primary bile acid mostly implicated in cholestatic liver injury. In this study, we have
investigated the involvement of membrane fluidity and cytochrome c release in CDCA-induced mitochondrial permeability
transition (MPT), and the preventive role of carvedilol. Treatment of calcium-loaded hepatic mitochondria with CDCA was
found to cause osmotic swelling and release of cytochrome c, associated with an increase in membrane fluidity, in both protein
and lipid regions. Carvedilol and cyclosporine A (CyA) reduced both cytochrome c release and alterations in membrane fluidity
induced by CDCA. The hydroxylated metabolite of carvedilol, BM-910228, had no effect. Thus, modulation of membrane
fluidity, plays an important role in MPT pore opening promoted by CDCA. As a result, we have delineated a pathway for the
preventive role of carvedilol in mitochondrial dysfunction induced by CDCA.
q 2003 Elsevier Science B.V. and Mitochondria Research Society. All rights reserved.
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1. Introduction
Bile formation is a vital function of the liver and its
impairment is central in the pathogenesis of choles-
tasis. In cholestatic disease, intrahepatic accumulation
of toxic bile acids promote hepatic injury (Greim et al.,
1972). Additionally, a possible relationship between
plasma accumulation of bile acids and the cardiomyo-
pathy of cholestatic liver disease has been proposed
(Joubert, 1978). CDCA is a primary bile acid mostly
implicated in liver injury. Hepatic levels of CDCA
increase 20-fold during cholestasis and are greater
than those of other toxic bile acids such as lithocholate
and deoxycholate (Greim et al., 1973).
Although the cellular mechanisms involved in bile
acid-induced injury are still under investigation, it is
known that hydrophobic bile acids are particularly
hepatotoxic. Due to their membrane-active, detergent-
like properties, the cytotoxicity of bile acids has been
correlated to the degree of lipophilicity of the different
molecular species (Attili et al., 1986). Mechanisms
implicated in the toxicity of bile acids include
stimulation of lipid peroxidation (Sokol et al., 1993)
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and induction of mitochondrial dysfunction (Schaff-
ner et al., 1971; Krahenbuhl et al., 1992; Gores et al.,
1998; Rolo et al., 2000).
Carvedilol, a multiple-action neuro-hormonal
antagonist with known cardioprotective effects, has
been previously described (Rolo et al., 2001) as a
protective agent against liver mitochondrial damage
induced by CDCA.
Induction of the mitochondrial permeability tran-
sition (MPT) is widely implicated in the pathophy-
siology of cell death caused by a number of agents
(Lemasters et al., 1998). It is characterized by an
increase in non-specific permeability of the inner
membrane to low molecular weight solutes leading to
mitochondrial membrane depolarization, mitochon-
drial calcium release, mitochondrial swelling and
inhibition of oxidative phosphorylation (Zoratti and
Szabo, 1995). Swelling then leads to outer membrane
rupture and release of cytochrome c and other
proapoptotic factors (Lemasters, 1999). The MPT is
suggested to reflect the opening of a pore composed of
assorted elements, the formation of which is inhibited
by cyclosporine A (CyA) (Broekemeier et al., 1989).
An association between MPT and changes in
mitochondrial membrane fluidity has been described
(Ricchelli et al., 1999), probably related with
conformational changes during the assembly of
membrane-spanning proteins into a non-specific pore.
In this study, we examined CDCA-induced MPT
events such as mitochondrial swelling, cytochrome c
release, and changes in mitochondrial membrane
fluidity, as probed by membrane labeling with
fluorescent dyes. We therein investigated the effects
of carvedilol and its metabolite BM-910228 on the
CDCA-induced MPT in rat liver mitochondria.
2. Materials and methods
2.1. Chemicals
CDCA, used as ethanolic solution, hematopor-
phyrin IX (HP), and 1,6-diphenyl-1,3,5-hexatriene
(DPH), were purchased from Sigma Chemical Co.
Carvedilol and BM-910228 were obtained from
Boehringer. All other chemicals were of the highest
grade of purity commercially available.
2.2. Isolation of mitochondria
Mitochondria were isolated from liver of male
Wistar rats by conventional methods (Gazotti et al.,
1979) with slight modifications. Homogenization
medium contained 250 mM sucrose, 10 mM HEPES
(pH 7.4), 0.5 mM EGTA, and 0.1% fat-free BSA.
EGTA and BSA were omitted from the final washing
medium, adjusted at pH 7.4. The mitochondrial pellet
was washed twice, suspended in the washing medium,
and immediately used. Protein content was deter-
mined by the biuret method (Gornall et al., 1949)
calibrated with BSA.
2.3. Measurement of mitochondrial permeability
transition
Mitochondrial swelling was estimated by changes
in light scattering as monitored spectrophotometri-
cally at 540 nm (Palmeira and Wallace, 1997). The
reaction medium was stirred continuously and the
temperature maintained at 258C. The experiments
were started by the addition of 1 mg of mitochondria
to a final volume of 2 ml of the standard incubation
medium, supplemented with 2 mM rotenone, 0.5 mg
of oligomycin, and 5 mM succinate. Calcium (35 mM
CaCl2) was added prior to all the other compounds.
2.4. Cytochrome c assay
The release of cytochrome c by isolated mitochon-
dria was determined spectrophotometrically at
410 nm. The reactions were carried out at 258C, in
2 ml of the standard incubation medium, sup-
plemented with 2 mM rotenone, 0.5 mg of oligomycin,
and 5 mM succinate. Mitochondria (2 mg/ml) were
suspended with gentle shaking for 30 min, in the
presence of different additions as shown in the legends
to the figures. After incubation, cytochrome c release
was evaluated as previously described (Appaix et al.,
2000). Quantification was achieved by employing a
standard curve. Cytochrome c release induced by the
test agents was expressed as a percent of total release,
which was evaluated after incubation of mitochondria
in a hypotonic medium.
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2.5. Mitochondrial membrane fluidity analysis
Membrane fluidity changes induced by the test
agents were evaluated by assessing the fluorescence
polarization of mitochondria bound dyes. The P value
for the probes fluorescence was used as a measure of
membrane fluidity, with increased polarization indi-
cating a decreased extent of phospholipid acyl chain
motion within the membrane (Kawato et al., 1977).
Two probes were used: HP (excitation 520 nm;
emission 626 nm) and DPH (excitation 340 nm;
emission 460 nm), that monitor the fluidity of
different regions of membranes. With the DPH
probe, fluidity of highly hydrophobic lipid phases is
evaluated (Kawato et al., 1977). HP has been
described as accumulating in very-polar, specific,
localized lipid regions, such as protein regions in the
inner mitochondrial membrane (Ricchelli et al.,
1995). HP (final concentration of 3 mM) was injected
into stirred mitochondrial suspensions (0.5 mg/ml of
the standard incubation medium) and the mixture
incubated for 2 min before measurements; DPH (final
concentration of 2 mM) required longer incubation
times (1 h). The different additions are shown in the
legends to the figures.
2.6. Statistical analysis
All data are expressed as the mean ^ SEM for four
independent experiments. Statistical evaluation was
performed using the two-tailed paired Student’s t test.
A P value ,0.05 was considered statistically
significant.
3. Results
3.1. CDCA-induced mitochondrial swelling
Fig. 1 reports mitochondrial swelling due to MPT
induction by CDCA (50 mM), in succcinate-ener-
gized, rat liver mitochondria. In the presence of
calcium (35 mM), hepatic mitochondria underwent a
large amplitude decrease of light scattering, upon
addition of CDCA. No swelling was observed in the
control experiment (Fig. 1) following calcium
addition, showing that mitochondria maintained
their permeability barrier. CyA prevented CDCA-
induced mitochondrial swelling, indicating that the
decrease in absorbance was the result of the calcium-
dependent MPT. A similar result was observed after
pre-incubation with carvedilol (10 mM), whereas BM-
910228 (10 mM) had no significant effect (Fig. 1).
3.2. CDCA-induced cytochrome c release
Fig. 2 shows the release of cytochrome c into the
medium after MPT induction by CDCA, in calcium
loaded mitochondria. A remarkable increase in
cytochrome c in the medium was observed in the
presence of both calcium and CDCA. Similar to the
swelling experiments, CyA had a preventive role,
associated with inhibition of the MPT. Carvedilol was
also effective, since pre-incubation with this com-
pound strongly prevented CDCA-induced MPT and
the associated cytochrome c release. In contrast, BM-
910228 had no effect on the mitochondrial response to
CDCA addition.
Fig. 1. Effects on mitochondrial swelling. The incubation medium
(final volume 2 ml at 258C) contained 200 mM sucrose, 10 mM
Tris–Mops (pH 7.4), 1 mM KH2PO4, and 10 mM EGTA sup-
plemented with 3 mM rotenone, 0.5 mg oligomycin, and 5 mM
succinate. The experiments were started by the addition of 1 mg of
mitochondria (not shown). After establishing a baseline, calcium
was added (35 mM). Where indicated (first arrow), CyA (1 mM),
carvedilol (Carv, 10 mM), or BM-910228 (10 mM) were included in
the reaction medium prior to 50 mM CDCA. The traces are typical
of several independent experiments with four different mitochon-
drial preparations.
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3.3. CDCA-induced alterations in membrane fluidity
To determine whether CDCA-induced mitochon-
drial swelling was related to changes in membrane
fluidity, DPH and HP fluorescence polarization values
were analyzed spectrofluorometrically (Fig. 3A, B ,
respectively). DPH reflects the fluidity of all mem-
brane layers (Kawato et al., 1977); HP typically
probes protein regions (Ricchelli et al., 1995). In the
presence of CDCA, there was a decrease in polariz-
ation values for DPH (Fig. 3A), showing that CDCA
by itself causes an increase in membrane fluidity.
Furthermore, in the presence of both calcium and
CDCA, there was a significant increase in membrane
fluidity, which appeared to parallel the light scattering
change. The strict correlation between changes in
membrane fluidity and the increase of permeability
due to MPT induction, was demonstrated by the
inhibitory effect of CyA. Carvedilol had a similar
effect. In contrast, in the presence of BM-910228, the
changes in DPH polarization were similar to those
observed in the presence of both calcium and CDCA.
Fig. 3B reports the effect of CDCA-induced MPT
on the membrane fluidity, as probed by HP. It has
Fig. 2. Effects on cytochrome c release. Mitochondria were
incubated in 2 ml of standard incubation medium, supplemented
with 3 mM rotenone, 0.5 mg oligomycin, and 5 mM succinate. As
shown in the figure, different test agents were added: calcium
(35 mM) and/or CDCA (50 mM); where indicated CyA (1 mM),
carvedilol (Carv, 10 mM), or BM-910228 (10 mM) was included in
the reaction medium prior to CDCA. After incubation (20 min),
cytochrome c release into the medium was evaluated as previously
described (Appaix et al., 2000). The effects of the test agents are
expressed as percent of total release, taking into account the
complete release of cytochrome c following incubation of
mitochondria in a hypotonic medium. Data represent the mean ^
SEM of measurements from four different mitochondrial prep-
arations. Values that share the same letter are not statistically
different ðP , 0:05Þ, compared by the two-tailed paired Student’s t
test.
Fig. 3. (A,B) Effects of CDCA on mitochondrial membrane fluidity
as probed by DPH (A) and HP (B). Following incubation with the
probes, the different test agents were added to mitochondria
suspended in 2 ml of standard incubation medium (supplemented
with 3 mM rotenone, 0.5 mg oligomycin, and 5 mM succinate). The
conditions were the same as described for Fig. 2. The changes in
polarization were monitored for a period of time similar to the one
considered in the swelling experiment (20 min). The effects of the
test agents are expressed as changes in the polarization values. Data
represent the mean ^ SEM of measurements from four different
mitochondrial preparations. Values that share the same letter are not
statistically different ðP , 0:05Þ, compared by the two-tailed paired
Student’s t test.
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been described that HP accumulates in specific,
localized lipid regions, perhaps in the boundary lipids
area surrounding some inner-mitochondrial carriers
(Ricchelli et al., 1995). After CDCA addition to
calcium-loaded mitochondria, there was a decrease in
polarization values, which was prevented by both
CyA and carvedilol. BM-910228 had no effect.
4. Discussion
Our previous study (Rolo et al., 2001) has
demonstrated that carvedilol displays a novel role,
preventing mitochondrial dysfunction associated with
the MPT induction by CDCA. In the present study, we
further demonstrate that MPT induction by CDCA is
associated with changes in mitochondrial membrane
fluidity, that are inhibited by carvedilol but not by its
hydroxylated analog, BM-910228. So, prevention by
carvedilol could be related with the physical stabil-
ization of mitochondrial membrane, as opposed to
disturbance induced by CDCA. Interestingly, work
made by others (Rodrigues et al., 1999, 2000) has
demonstrated that hydrophilic bile acids, such as
ursodeoxycholic (UDCA) and its taurine derivative
(TUDC), are inhibitors of apoptosis via stabilization
of the mitochondrial membrane, through pathways
that are independent of the MPT. In fact, these studies
regarding induction of apoptosis through a mitochon-
drial-dependent pathway, have showed that, although
there was no protection by CyA, UDCA or TUDC,
were able to prevent cell death. The proposed
mechanism for hydrophilic bile acids protection
correlates inhibition of mitochondrial depolarization
and outer membrane disruption, together with modu-
lation of Bax translocation from cytosol to mitochon-
dria. This similarity of cytoprotective actions of both
carvedilol and hydrophilic bile acids may reflect
modulation of membrane perturbation due to their
lipophilicity. In contrast, and in concordance with our
results, CyA blocked MPT and also prevented
mitochondrial swelling and reduced the efflux of
cytochrome c induced by deoxycholic acid, a
hydrophobic bile acid, in primary rat hepatocytes
(Rodrigues et al., 1999). This suggests that, in contrast
to hydrophilic bile acids, cytotoxicity of hydrophobic
bile acids involve mitochondrial disruption and
cytochrome c release primarily through MPT
opening.
Hepatocellular damage in cholestasis is character-
ized by intracellular accumulation of bile acids
(Greim et al., 1972). Furthermore, cardiomyopathy
has been associated with cholestatic liver disease,
probably due to increased plasma levels of bile acids
(Joubert, 1978). A number of observations suggest
that mitochondria are a primary target of chemical
induced injury and that their dysfunction ultimately
leads to cell death (Petit et al., 1995; Wallace and
Starkov, 2000). Both morphological and biochemical
observations support the concept that bile acids may
be cytotoxic by causing mitochondrial dysfunction
(Schaffner et al., 1971; Krahenbuhl et al., 1992; Sokol
et al., 1993; Gores et al., 1998; Rolo et al., 2000),
particularly at the level of MPT induction. Besides
impairment of mitochondrial bioenergetics, permea-
bilization of the mitochondrial membrane releases
several proteins, including cytochrome c (Kluck et al.,
1997). In mitochondria, cytochrome c plays an
essential role in generation of mitochondrial trans-
membrane potential. Additionally, the release of
cytochrome c from the inter-membrane space into
cytosol also leads to the initiation of a prompt
apoptotic cascade (Li et al., 1997).
Here, we report that carvedilol and CyA prevent
CDCA-induced MPT and the associated cytochrome c
release. Moreover, using the hydroxylated metabolite
of carvedilol, shown to have higher antioxidant
activity than carvedilol (Yue et al., 1994), we did
not detect protection against CDCA-induced mem-
brane disturbance. Thus, these results are consistent
with a protection that occurs via the inhibition of the
MPT, and that is not related with the antioxidant
properties. However, the results do not exclude a
direct interaction with the MPT assembly, being
carvedilol able to inhibit mitochondrial membrane
disturbance caused by CDCA to calcium-loaded
mitochondria. This difference may reflect the different
properties of both carvedilol and BM-910228 in terms
of membrane insertion. Due to its great lipophilicity,
carvedilol has a considerable tendency for membrane
insertion (Cheng et al., 1996) and may disturb the
correct assembly of the pore proteic components. This
would explain the similar results obtained with CyA
and carvedilol. Indeed, the membrane fluidity studies,
reflecting the dynamic properties of mitochondrial
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membranes, regarding protein regions, as probed by
HP, show the strict correlation between the inhibitory
effect of carvedilol and the changes in the polarization
values due to pore opening.
We have observed that CDCA renders mitochon-
drial membranes more permeable, as shown by the
increased membrane fluidity, probed by DPH. It is
well established that hydrophobicity, as demonstrated
by its close correlation with the partition coefficient of
compounds, is often associated with biological action
(Hansch and Dunn, 1972). Bile acids, in particular the
lipophilic dihydroxy, such as CDCA, and monohy-
droxy species, are surface-active substances and can
damage biological membranes (Scholmerich et al.,
1984). Some reports, regarding in vitro studies, have
been shown direct effects of bile acids on membrane
fluidity (Isaacson and van Thiel, 1988; Schroder et al.,
1996), associated with increased proton permeability
of the membranes (Zhao and Hirst, 1990; Schroder
et al., 1996). This in accordance with our results, since
besides induced increased fluidity due to MPT
induction, CDCA also decreased DPH polarization
in non-calcium-loaded mitochondria. Furthermore,
CyA did not prevent this effect. However, CyA
completely protected against the calcium-dependent
swelling, cytochrome c release and HP-probed fluidity
changes. So, the already described stimulation of state
four respiration in isolated mitochondria (Rolo et al.,
2000), caused by CDCA, may be a consequence of
increased membrane fluidity.
In conclusion, our results indicate that alterations
in membrane fluidity are events involved in the
protection afforded by carvedilol against CDCA-
induced MPT, characterized by osmotic swelling
and cytochrome c release. The disturbance of
mitochondrial membrane by CDCA could lead to
impairment of mitochondrial function, and sub-
sequent cell dysfunction observed during cholestasis.
Since bile acid accumulation has been proposed as a
causative factor for hepatic cardiomyopathy, carve-
dilol administration may potentially prevent mito-
chondrial dysfunction associated with
cardiomyopathy in cholestatic liver disease.
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